Xeris Biopharma (NasdaqGS:XERS) Q4 2025 Earnings call March 02, 2026 08:30 AM ET Company ParticipantsAllison Wey - SVP of Corporate Communications and Investor RelationsBrandon Folkes - Managing DirectorJenna Davidner - VP of Equity ResearchJohn Shannon - CEOSteve Pieper - CFOConference Call ParticipantsChase Knickerbocker - Senior Equity Research AnalystDavid Amsellem - Managing Director and Senior Research AnalystDennis Ding - VP and Equity Research AnalystJason Dorr - Associate AnalystNone - AnalystOpera ...